Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lucerastat in Fabry Disease
NCT07778667Phase 3Recruiting
- Sponsor
- Idorsia
- Start
- Dec 2026
- Primary completion
- Feb 2029
- Countries
- 5
01
Overview
A Phase 3 trial of lucerastat in Fabry disease (FD), sponsored by Idorsia. Planned start Dec 2026; status: recruiting.
02
Drugs
lucerastat
03
Conditions
Fabry disease (FD)
Beyond the preview
Go deeper on NCT07778667.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07778667.